To investigate the prognostic and predictive value of PD-L2 DNA methylation, we examined PD-L2 DNA methylation in N = 129 patients with metastatic melanoma prior to anti-PD-1 immunotherapy. The gene discussed is PDCD1; the disease is metastatic melanoma.